Found: 3188
Select item for more details and to access through your institution.
Anti-angiogenic activity of polymeric nanoparticles loaded with ursolic acid.
- Published in:
- Journal of Drug Targeting, 2025, v. 33, n. 2, p. 249, doi. 10.1080/1061186X.2024.2409881
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 813, doi. 10.2147/ITT.S494670
- By:
- Publication type:
- Article
Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01763-5
- By:
- Publication type:
- Article
New acorane-sesequiterpenes and anti-retinoblastoma constituents from the marine algicolous fungus Trichoderma harzianum NTU2180 guided by molecular networking strategy.
- Published in:
- Botanical Studies, 2025, v. 66, n. 1, p. 1, doi. 10.1186/s40529-024-00449-5
- By:
- Publication type:
- Article
Fracionamento de seringas intravítreas de aflibercept e ranibizumab, utilizando técnica assética.
- Published in:
- Saúde & Tecnologia, 2024, n. 30, p. 1
- By:
- Publication type:
- Article
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
- Published in:
- BioScience Trends, 2024, v. 18, n. 6, p. 505, doi. 10.5582/bst.2024.01394
- By:
- Publication type:
- Article
Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.
- Published in:
- BioScience Trends, 2024, v. 18, n. 6, p. 495, doi. 10.5582/bst.2024.01423
- By:
- Publication type:
- Article
Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.
- Published in:
- Journal of Neuro-Oncology, 2025, v. 171, n. 2, p. 313, doi. 10.1007/s11060-024-04865-2
- By:
- Publication type:
- Article
Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2025, v. 171, n. 1, p. 201, doi. 10.1007/s11060-024-04828-7
- By:
- Publication type:
- Article
Identification of a Neutralizing scFv Binding to Human Vascular Endothelial Growth Factor 165 (VEGF165) Using a Phage Display Antibody Library.
- Published in:
- Applied Biochemistry & Biotechnology, 2008, v. 144, n. 1, p. 15, doi. 10.1007/s12010-007-8011-4
- By:
- Publication type:
- Article
Gold nanocrystals as potential inhibitors of tumor angiogenesis: implications in diagnosis and drug delivery.
- Published in:
- Journal of Nanoparticle Research, 2021, v. 23, n. 7, p. 1, doi. 10.1007/s11051-021-05276-4
- By:
- Publication type:
- Article
Anti-proliferative effects of gold nanoparticles functionalized with Semaphorin 3F.
- Published in:
- Journal of Nanoparticle Research, 2017, v. 19, n. 8, p. 1, doi. 10.1007/s11051-017-3967-7
- By:
- Publication type:
- Article
Anti-angiogenic activity and safety of intraocular application of triterpenes.
- Published in:
- Documenta Ophthalmologica, 2021, v. 143, n. 3, p. 259, doi. 10.1007/s10633-021-09841-z
- By:
- Publication type:
- Article
Psychological stress accelerates the onset of tumour formation and alters the type and location of tumours in a DMBA mouse carcinogenesis model.
- Published in:
- Stress & Health: Journal of the International Society for the Investigation of Stress, 2011, v. 27, n. 3, p. e129, doi. 10.1002/smi.1343
- By:
- Publication type:
- Article
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report.
- Published in:
- 2012
- By:
- Publication type:
- Report
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 4, p. 337, doi. 10.1007/s00280-023-04519-6
- By:
- Publication type:
- Article
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 867, doi. 10.1007/s00280-021-04326-x
- By:
- Publication type:
- Article
Renin-angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Advances in ovarian cancer therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of pazopanib plus TH-302 in advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetics of lenalidomide in multiple myeloma patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Population pharmacokinetics of bevacizumab in cancer patients with external validation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 243, doi. 10.1007/s00280-015-2748-1
- By:
- Publication type:
- Article
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 993, doi. 10.1007/s00280-015-2694-y
- By:
- Publication type:
- Article
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab‑refractory breast cancer model.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 425, doi. 10.1007/s00280-012-1923-x
- By:
- Publication type:
- Article
Antiangiogenic therapy in the management of brain tumors: a clinical overview.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 353, doi. 10.1007/s00280-012-1926-7
- By:
- Publication type:
- Article
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 333, doi. 10.1007/s00280-011-1685-x
- By:
- Publication type:
- Article
Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 173, doi. 10.1007/s00280-011-1681-1
- By:
- Publication type:
- Article
Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 239, doi. 10.1007/s00280-011-1695-8
- By:
- Publication type:
- Article
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 293, doi. 10.1007/s00280-010-1478-7
- By:
- Publication type:
- Article
Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1035, doi. 10.1007/s00280-010-1402-1
- By:
- Publication type:
- Article
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 799, doi. 10.1007/s00280-010-1378-x
- By:
- Publication type:
- Article
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 315, doi. 10.1007/s00280-010-1320-2
- By:
- Publication type:
- Article